Aj. Mceligot et al., Plasma carotenoids are biomarkers of long-term high vegetable intake in women with breast cancer, J NUTR, 129(12), 1999, pp. 2258-2263
We investigated predictors Df change in plasma carotenoids from baseline to
3 y and examined plasma carotenoid concentrations at 1 and 3 y in response
to a high vegetable diet. Participants were 56 women diagnosed with breast
cancer and enrolled in a randomized feasibility study for a trial examinin
g the effect of a diet high in vegetables and fruits on the risk of breast
cancer recurrence. Independent t test analysis revealed that the interventi
on group had significantly higher vegetable and fruit servings and fiber at
12 mo and significantly higher vegetable servings at 36 mo compared with t
he control group (P < 0.05). Energy intake from fat was significantly lower
in the intervention group at 12 and 36 mo. The intervention group had sign
ificantly higher consumption of beta-carotene, alpha-carotene, lutein and b
eta-cryptoxanthin at 12 mo (P < 0.05). beta-Carotene, alpha-carotene and lu
tein intakes also were significantly higher at 36 mo (P < 0.05). At 36 mo,t
he intervention group had significantly higher plasma concentrations of alp
ha-carotene and beta-carotene compared with the control group. Repeated-mea
sures ANOVA revealed that the intervention group had significantly increase
d (P < 0.05 with Bonferroni correction) plasma beta-carotene, alpha-caroten
e, lutein and lycopene concentrations at 12 and 36 mo compared with baselin
e. Baseline carotenoid concentrations were significantly inversely predicti
ve (P < 0.05) of plasma carotenoid change. In addition, change in body mass
index (BMI) and plasma cholesterol concentrations were predictive of plasm
a carotenoid change from baseline to 3 y. Results of this study demonstrate
that change in plasma carotenoid concentrations is associated with change
in BMI, change in plasma cholesterol and baseline carotenoid concentrations
. Plasma carotenoid response can be an indicator of long-term high vegetabl
e intake for women at risk of breast cancer recurrence.